Only followers of this user (HopeAlways888) can see their posts
The emergency use authorization was only narrowly approved (13-10) because of questions regarding efficacy and concerns that molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID-19 pandemic.
04:13 AM - Jul 08, 2022
In response Hope Always888 to her Publication
Only people mentioned by TrishM in this post can reply
